First Busey Corporation heads into its July 21 earnings release with the Street turning more constructive and the stock quietly putting together one of its better months of the year.
The analyst story is the clearest signal this week. Two firms raised their price targets on BUSE in the past week alone. Raymond James lifted its target from $28 to $32 on July 1, keeping an Outperform rating. Piper Sandler made the same move on June 26 — taking its target from $30 to $32 while holding Overweight. Both actions are consistent with a broader pattern: every analyst move since January 2026 has been a raise. The consensus mean target now sits at $32 from the two most active covering firms, sitting fractionally above the current price of $29.50. The bull case centers on treasury and wealth management revenue growth, a stable CET1, and the prospect of a declining loan-loss provision. Bears flag loan shrinkage, soft core fee income, and the absence of near-term M&A optionality to deploy excess capital. The dividend score ranks in the 92nd percentile of the universe — income-oriented holders have had little to complain about, at least on that front.
Short interest is worth a mention, though the picture here is less charged than the analyst activity suggests. SI sits at roughly 4.4% of the free float — a moderate level that has drifted about 17% higher over the past month. There was a notable single-session drop of 12% on June 30, following a spike to around 4.46 million shares the prior session. That intraday volatility looks more like positioning noise than a directional shift. Borrow conditions are loose: availability is running at over 2,200% of current short interest, meaning shares to borrow are plentiful relative to the existing short base. Cost to borrow has climbed roughly 46% over the past week to 0.54%, but in absolute terms that remains a very low rate. The short score of 43.5 sits in the lower half of the universe, and the short score rank is in just the 14th percentile — there is no meaningful short-side pressure building here.
Options positioning points in the same direction. The put/call ratio is running slightly below its 20-day average of 0.12, at 0.115 — meaning call volume is dominating. With a z-score of roughly -0.87, options traders are leaning mildly bullish rather than bracing for a drawdown. The PCR has drifted lower through June from readings around 0.13 in early May, and the 52-week low for the ratio is zero, so there is room for it to compress further if buying interest picks up into earnings.
The stock itself has gained 2.1% on the week and 7.8% over the past month, making it one of BUSE's stronger stretches in recent history. Among closely correlated peers, CVBF gained 4.6% on the week and SRCE added 3.3%, suggesting the regional bank space broadly caught a bid. BANF was the outlier, slipping 0.8% over the same period. BUSE's move is solid but not dramatically ahead of the peer group — the relative performance looks earned rather than stretched.
Insider activity in the 90-day window is net positive in share count terms — a small director purchase in May was partially offset by routine director sells from one individual. The CEO and several C-suite officers sold modest amounts back in late March at prices around $24.96, well below current levels, which in hindsight reads as unremarkable profit-taking rather than a negative signal.
The next focal point is the Q1 earnings release scheduled for July 21, where deposit trends, net interest margin trajectory, and any update on loan-loss provision guidance will be the metrics worth watching most closely.
See the live data behind this article on ORTEX.
Open BUSE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
